548 related articles for article (PubMed ID: 31072400)
21. Synovial Immunohistological Biomarkers of the Classification of Undifferentiated Arthritis Evolving to Rheumatoid or Psoriatic Arthritis.
Cuervo A; Celis R; Julià A; Usategui A; Faré R; Ramírez J; Azuaga AB; Lorenzo A; Sanmartí R; Pablos JL; Cañete JD
Front Med (Lausanne); 2021; 8():656667. PubMed ID: 33898490
[No Abstract] [Full Text] [Related]
22. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
[TBL] [Abstract][Full Text] [Related]
23. High-grade synovitis associates with clinical markers and response to therapy in chronic inflammatory arthritis:
Garaffoni C; Tamussin M; Calciolari I; Lanza G; Bortoluzzi A; Scirè CA; Govoni M; Silvagni E
Front Immunol; 2023; 14():1298583. PubMed ID: 38274811
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis.
Boutet MA; Nerviani A; Lliso-Ribera G; Lucchesi D; Prediletto E; Ghirardi GM; Goldmann K; Lewis M; Pitzalis C
Rheumatology (Oxford); 2020 Apr; 59(4):828-838. PubMed ID: 31504934
[TBL] [Abstract][Full Text] [Related]
25. Addition of Fibroblast-Stromal Cell Markers to Immune Synovium Pathotypes Better Predicts Radiographic Progression at 1 Year in Active Rheumatoid Arthritis.
Zhang XP; Ma JD; Mo YQ; Jing J; Zheng DH; Chen LF; Wu T; Chen CT; Zhang Q; Zou YY; Lin JZ; Xu YH; Zou YW; Yang ZH; Ling L; Miossec P; Dai L
Front Immunol; 2021; 12():778480. PubMed ID: 34887865
[TBL] [Abstract][Full Text] [Related]
26. B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status.
Michelutti A; Gremese E; Morassi F; Petricca L; Arena V; Tolusso B; Alivernini S; Peluso G; Bosello SL; Ferraccioli G
Mol Med; 2011; 17(9-10):901-9. PubMed ID: 21607290
[TBL] [Abstract][Full Text] [Related]
27. Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation.
Alenius GM; Berglin E; Rantapää Dahlqvist S
Ann Rheum Dis; 2006 Mar; 65(3):398-400. PubMed ID: 16096328
[TBL] [Abstract][Full Text] [Related]
28. Laboratory findings in psoriatic arthritis.
Punzi L; Podswiadek M; Oliviero F; Lonigro A; Modesti V; Ramonda R; Todesco S
Reumatismo; 2007; 59 Suppl 1():52-5. PubMed ID: 17828345
[TBL] [Abstract][Full Text] [Related]
29. Identification of autoantibodies against PsoP27 in synovial fluid derived from psoriatic arthritis and rheumatoid arthritis patients.
Slobodkin M; Polachek A; Furer V; Elkayam O; Gertel S
Scand J Clin Lab Invest; 2024 May; 84(3):211-217. PubMed ID: 38767606
[TBL] [Abstract][Full Text] [Related]
30. Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis.
Greven DE; Cohen ES; Gerlag DM; Campbell J; Woods J; Davis N; van Nieuwenhuijze A; Lewis A; Heasmen S; McCourt M; Corkill D; Dodd A; Elvin J; Statache G; Wicks IP; Anderson IK; Nash A; Sleeman MA; Tak PP
Ann Rheum Dis; 2015 Oct; 74(10):1924-30. PubMed ID: 24936585
[TBL] [Abstract][Full Text] [Related]
31. Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate.
Kane D; Gogarty M; O'leary J; Silva I; Bermingham N; Bresnihan B; Fitzgerald O
Arthritis Rheum; 2004 Oct; 50(10):3286-95. PubMed ID: 15476228
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
[TBL] [Abstract][Full Text] [Related]
33. Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy--a single centre, open-label study.
Pontifex EK; Gerlag DM; Gogarty M; Vinkenoog M; Gibbs A; Burgman I; Fearon U; Bresnihan B; Tak PP; Gibney RG; Veale DJ; FitzGerald O
Arthritis Res Ther; 2011 Jan; 13(1):R7. PubMed ID: 21272347
[TBL] [Abstract][Full Text] [Related]
34. CD209/CD14
Marzaioli V; Canavan M; Floudas A; Flynn K; Mullan R; Veale DJ; Fearon U
Front Immunol; 2021; 12():722349. PubMed ID: 35095831
[TBL] [Abstract][Full Text] [Related]
35. Distinct
Baricza E; Marton N; Királyhidi P; Kovács OT; Kovácsné Székely I; Lajkó E; Kőhidai L; Rojkovich B; Érsek B; Buzás EI; Nagy G
Front Immunol; 2018; 9():606. PubMed ID: 29670615
[TBL] [Abstract][Full Text] [Related]
36. Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis?
Pincus T; Bergman MJ; Yazici Y
Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S82-93. PubMed ID: 26472658
[TBL] [Abstract][Full Text] [Related]
37. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis.
Inanc N; Dalkilic E; Kamali S; Kasapoglu-Günal E; Elbir Y; Direskeneli H; Inanc M
Clin Rheumatol; 2007 Jan; 26(1):17-23. PubMed ID: 16538391
[TBL] [Abstract][Full Text] [Related]
38. Increased interleukin-26 in the peripheral joints of patients with axial spondyloarthritis and psoriatic arthritis, co-localizing with CD68-positive synoviocytes.
Hammitzsch A; Ossadnik A; Bachmann Q; Merwald-Fraenk H; Lorenz G; Witt M; Wiesent F; Mühlhofer H; Simone D; Bowness P; Heemann U; Arbogast M; Moog P; Schmaderer C
Front Immunol; 2024; 15():1355824. PubMed ID: 38799447
[TBL] [Abstract][Full Text] [Related]
39. Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.
Talabot-Ayer D; McKee T; Gindre P; Bas S; Baeten DL; Gabay C; Palmer G
Joint Bone Spine; 2012 Jan; 79(1):32-7. PubMed ID: 21441054
[TBL] [Abstract][Full Text] [Related]
40. Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis.
Alivernini S; Pugliese D; Tolusso B; Bui L; Petricca L; Guidi L; Mirone L; Rapaccini GL; Federico F; Ferraccioli G; Armuzzi A; Gremese E
RMD Open; 2018; 4(1):e000667. PubMed ID: 29657833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
